MAPT and Alzheimer disease: We therefore first examined the protein levels of AD pathogenic markers, including Aβ42 and the phosphorylation of Tau at Ser-199 and Ser-202 (p-TauS199/202) and phosphorylation of APP at Thr-668 (p-APPT668) in post-mortem samples.